Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Special fats proven essential for brain growth

  • Earthquakes prove to be an unexpected help in interpreting brain activity of very premature babies

  • Can you see what I hear? Blind human echolocators use visual areas of the brain

  • Study on neurogenesis in the olfactory bulb

  • Scientists create mice with a major genetic cause of ALS, frontotemporal dementia

  • Breastfeeding protects against environmental pollution

  • How a schizophrenia risk gene affects the brain

  • New mechanism for Alzheimer's disease confirmed

  • Proteins may slow memory loss in people with Alzheimer's

  • Experts map surgical approaches for auditory brainstem implantation

  •